目次

Table of Contents

Chapter 1. Hereditary Testing Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Disease Type
1.1.1.2. Technology Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Hereditary Testing Market: Executive Summary
2.1. Market Snapshot
2.2. Disease Type Technology Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Hereditary Testing Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Increase in sales and demand for DNA test kits
3.4.2. Constantly developing commercial landscape of women's reproductive health
3.4.3. Decline in sequencing cost & consequent expansion of genetic testing registry
3.5. Market Restraint Analysis
3.5.1. Ethical and clinical issues of DNA tests
3.5.2. Regulatory challenges pertaining to use of DTC genetic tests
3.6. Market Opportunity Analysis
3.6.1. Increasing incidence of genetic diseases
3.6.2. Presence of demand for early and non-invasive fetal testing procedures
3.6.3. Introduction of fragmented point-solutions across the genomics value chain
3.7. Porter’s Five Forces Analysis
3.8. PESTLE Analysis
3.9. Pipeline Analysis

Chapter 4. Hereditary Testing Market: Disease Type Estimates & Trend Analysis
4.1. Hereditary Testing Market: Disease Type Movement Analysis
4.2. Hereditary Cancer Testing
4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.2. Breast Cancer
4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.3. Lung Cancer
4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.4. Colorectal Cancer
4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.5. Cervical Cancer
4.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.6. Ovarian Cancer
4.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.7. Prostate Cancer
4.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.8. Stomach/Gastric Cancer
4.2.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.9. Melanoma
4.2.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.10. Sarcoma
4.2.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.11. Uterine Cancer
4.2.11.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.12. Pancreatic Cancer
4.2.12.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.2.13. Others
4.2.13.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Hereditary Non-cancer Testing
4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2. Genetic Tests
4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.2. Cardiac Diseases
4.3.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.3. Rare Diseases
4.3.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.4. Other Diseases
4.3.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3. Preimplantation Genetic Diagnosis & Screening
4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.4. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.5. Newborn Genetic Screening
4.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hereditary Testing Market: Technology Estimates & Trend Analysis
5.1. Hereditary Testing Market: Technology Movement Analysis
5.2. Cytogenetic
5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Biochemical
5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Molecular Testing
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hereditary Testing Market: Regional Business Analysis
6.1. Regional Market Snapshot
6.2. North America
6.2.1. North America Hereditary Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Hereditary Testing Market, 2021 - 2033 (USD Million)
6.2.2.2. Key Country Dynamics
6.2.2.3. Regulatory Framework
6.2.2.4. Reimbursement Scenario
6.2.2.5. Competitive Scenario
6.2.3. Canada
6.2.3.1. Canada Hereditary Testing Market, 2021 - 2033 (USD Million)
6.2.3.2. Key Country Dynamics
6.2.3.3. Regulatory Framework
6.2.3.4. Reimbursement Scenario
6.2.3.5. Competitive Scenario
6.2.4. Mexico
6.2.4.1. Mexico Hereditary Testing Market, 2021 - 2033 (USD Million)
6.2.4.2. Key Country Dynamics
6.2.4.3. Regulatory Framework
6.2.4.4. Reimbursement Scenario
6.2.4.5. Competitive Scenario
6.3. Europe
6.3.1. Europe Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.2. UK
6.3.2.1. UK Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.2.2. Key Country Dynamics
6.3.2.3. Regulatory Framework
6.3.2.4. Reimbursement Scenario
6.3.2.5. Competitive Scenario
6.3.3. Germany
6.3.3.1. Germany Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.3.2. Key Country Dynamics
6.3.3.3. Regulatory Framework
6.3.3.4. Reimbursement Scenario
6.3.3.5. Competitive Scenario
6.3.4. Spain
6.3.4.1. Spain Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.4.2. Key Country Dynamics
6.3.4.3. Regulatory Framework
6.3.4.4. Reimbursement Scenario
6.3.4.5. Competitive Scenario
6.3.5. France
6.3.5.1. France Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.5.2. Key Country Dynamics
6.3.5.3. Regulatory Framework
6.3.5.4. Reimbursement Scenario
6.3.5.5. Competitive Scenario
6.3.6. Italy
6.3.6.1. Italy Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.6.2. Key Country Dynamics
6.3.6.3. Regulatory Framework
6.3.6.4. Reimbursement Scenario
6.3.6.5. Competitive Scenario
6.3.7. Denmark
6.3.7.1. Denmark Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.7.2. Key Country Dynamics
6.3.7.3. Regulatory Framework
6.3.7.4. Reimbursement Scenario
6.3.7.5. Competitive Scenario
6.3.8. Sweden
6.3.8.1. Sweden Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.8.2. Key Country Dynamics
6.3.8.3. Regulatory Framework
6.3.8.4. Reimbursement Scenario
6.3.8.5. Competitive Scenario
6.3.9. Norway
6.3.9.1. Norway Hereditary Testing Market, 2021 - 2033 (USD Million)
6.3.9.2. Key Country Dynamics
6.3.9.3. Regulatory Framework
6.3.9.4. Reimbursement Scenario
6.3.9.5. Competitive Scenario
6.4. Asia Pacific
6.4.1. Asia-Pacific Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.2.2. Key Country Dynamics
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Scenario
6.4.2.5. Competitive Scenario
6.4.3. China
6.4.3.1. China Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.3.2. Key Country Dynamics
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Scenario
6.4.3.5. Competitive Scenario
6.4.4. India
6.4.4.1. India Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.4.2. Key Country Dynamics
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Scenario
6.4.4.5. Competitive Scenario
6.4.5. South Korea
6.4.5.1. South Korea Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.5.2. Key Country Dynamics
6.4.5.3. Regulatory Framework
6.4.5.4. Reimbursement Scenario
6.4.5.5. Competitive Scenario
6.4.6. Thailand
6.4.6.1. Thailand Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.6.2. Key Country Dynamics
6.4.6.3. Regulatory Framework
6.4.6.4. Reimbursement Scenario
6.4.6.5. Competitive Scenario
6.4.7. Australia
6.4.7.1. Australia Hereditary Testing Market, 2021 - 2033 (USD Million)
6.4.7.2. Key Country Dynamics
6.4.7.3. Regulatory Framework
6.4.7.4. Reimbursement Scenario
6.4.7.5. Competitive Scenario
6.5. Latin America
6.5.1. Latin America Hereditary Testing Market, 2021 - 2033 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Hereditary Testing Market, 2021 - 2033 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Competitive Scenario
6.5.3. Argentina
6.5.3.1. Argentina Hereditary Testing Market, 2021 - 2033 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Competitive Scenario
6.6. Middle East & Africa
6.6.1. Middle East & Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. Competitive Scenario
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Hereditary Testing Market, 2021 - 2033 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Competitive Scenario
6.6.4. UAE
6.6.4.1. UAE Hereditary Testing Market, 2021 - 2033 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. Competitive Scenario
6.6.5. Kuwait
6.6.5.1. Kuwait Hereditary Testing Market, 2021 - 2033 (USD Million)
6.6.5.2. Key Country Dynamics
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Competitive Scenario

Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. New Product Launch
7.2.2. Partnerships
7.2.3. Acquisition
7.2.4. Collaboration
7.2.5. Funding
7.3. Key Company Market Share Analysis, 2024
7.4. Company Heat Map Analysis
7.5. Company Profiles
7.5.1. Myriad Genetics, Inc.
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Invitae Corporation
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Illumina, Inc.
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Natera, Inc.
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Laboratory Corporation of America Holdings
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. F. Hoffmann-La Roche Ltd.
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Quest Diagnostics Incorporated
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. COOPERSURGICAL, INC.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Agilent Technologies, Inc.
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Thermo Fisher Scientific, Inc.
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. Twist Bioscience
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. SOPHiA GENETICS
7.5.12.1. Company Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. Fulgent Genetics
7.5.13.1. Company Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
7.5.14. MedGenome
7.5.14.1. Company Overview
7.5.14.2. Financial Performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic Initiatives
7.5.15. CENTOGENE N.V.
7.5.15.1. Company Overview
7.5.15.2. Financial Performance
7.5.15.3. Product Benchmarking
7.5.15.4. Strategic Initiatives
List of Tables
Table 1 Product mapping for hereditary cancer tests
Table 2 DNA sequencing costs over the past decade
Table 3 Global incidence rate of genetic disorders
Table 4 Technology landscape for NIPT tests
Table 5 Comparison of other technologies
Table 6 Countries that prescribe mandatory medical supervision & restriction for genetic tests
Table 7 Susceptibility genes and their prevalence in hereditary ovarian syndromes
Table 8 Various NGS tests for hereditary prostate cancer
Table 9 Genetic testing scenario for patients/families affected by inherited cardiac disease
Table 10 Financial solutions for PGT:
Table 11 Commercial landscape of NIPT for fetal aneuploidy in the U.S.
Table 12 North America hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 16 North America hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 17 U.S. hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 18 U.S. hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 19 Canada hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 20 Canada hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 21 Mexico hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 22 Mexico hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 23 Europe hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 35 Europe hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 36 UK hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 37 UK hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 38 Germany hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 39 Germany hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 40 France hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 41 France hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 42 Spain hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 43 Spain hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 43 Italy hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 44 Italy hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 45 Denmark hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 46 Denmark hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 47 Sweden hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 48 Sweden hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 49 Norway hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 50 Norway hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 51 Asia Pacific hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 52 Asia Pacific hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 53 China hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 54 China hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 55 Japan hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 56 Japan hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 57 India hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 58 India hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 59 South Korea hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 60 South Korea hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 61 Australia hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 62 Australia hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 63 Thailand hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 64 Thailand hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 65 Latin America hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 66 Latin America hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 67 Brazil hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 68 Brazil hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 69 Argentina hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 70 Argentina hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 71 Middle East & Africa hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 72 Middle East & Africa hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 73 South Africa hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 74 South Africa hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 75 Saudi Arabia hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 76 Saudi Arabia hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 77 UAE hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 79 UAE hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
Table 80 Kuwait hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
Table 81 Kuwait hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Hereditary Testing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2024
Fig. 15 Regional Marketplace: Key Takeaways
Fig. 16 Regional Outlook, 2024 & 2033
Fig. 17 North America Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 18 U.S. Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 19 Mexico Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 19 Canada Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 20 Europe Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 21 Germany Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 22 UK Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 23 France Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 24 Spain Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 25 Italy Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 26 Denmark Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 27 Sweden Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 28 Norway Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 29 Asia Pacific Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 30 Japan Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 31 China Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 32 India Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 33 Australia Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 34 South Korea Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 35 Thailand Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 36 Latin America Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 37 Brazil Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 39 Argentina Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 40 Middle East and Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 41 South Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 42 Saudi Arabia Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 43 UAE Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 44 Kuwait Hereditary Testing Market, 2021 - 2033 (USD Million)
Fig. 45 Global Hereditary Testing Market, for, Hereditary Cancer Testing 2021 - 2033 (USD Million)
Fig. 46 Global Hereditary Testing Market, for, Lung Cancer 2021 - 2033 (USD Million)
Fig. 47 Global Hereditary Testing Market, for, Breast Cancer 2021 - 2033 (USD Million)
Fig. 48 Global Hereditary Testing Market, for, Colorectal Cancer 2021 - 2033 (USD Million)
Fig. 49 Global Hereditary Testing Market, for, Cervical Cancer 2021 - 2033 (USD Million)
Fig. 50 Global Hereditary Testing Market, for, Ovarian Cancer 2021 - 2033 (USD Million)
Fig. 51 Global Hereditary Testing Market, for, Prostate Cancer 2021 - 2033 (USD Million)
Fig. 52 Global Hereditary Testing Market, for, Stomach/Gastric Cancer 2021 - 2033 (USD Million)
Fig. 53 Global Hereditary Testing Market, for, Melanoma 2021 - 2033 (USD Million)
Fig. 54 Global Hereditary Testing Market, for, Sarcoma 2021 - 2033 (USD Million)
Fig. 55 Global Hereditary Testing Market, for, Uterine Cancer 2021 - 2033 (USD Million)
Fig. 56 Global Hereditary Testing Market, for, Pancreatic Cancer 2021 - 2033 (USD Million)
Fig. 57 Global Hereditary Testing Market, for, Others 2021 - 2033 (USD Million)
Fig. 58 Global Hereditary Testing Market, for, Genetic Tests 2021 - 2033 (USD Million)
Fig. 59 Global Hereditary Testing Market, for, Cardiac Diseases 2021 - 2033 (USD Million)
Fig. 60 Global Hereditary Testing Market, for, Rare Diseases 2021 - 2033 (USD Million)
Fig. 61 Global Hereditary Testing Market, for, Other Diseases 2021 - 2033 (USD Million)
Fig. 62 Global Hereditary Testing Market, for, Newborn Genetic Screening 2021 - 2033 (USD Million)
Fig. 63 Global Hereditary Testing Market, for, Preimplantation Genetic Diagnosis & Screening 2021 - 2033 (USD Million)
Fig. 64 Global Hereditary Testing Market, for, Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests 2021 - 2033 (USD Million)
Fig. 65 Global Hereditary Testing Market, for, Cytogenetic 2021 - 2033 (USD Million)
Fig. 66 Global Hereditary Testing Market, for, Biochemical 2021 - 2033 (USD Million)
Fig. 67 Global Hereditary Testing Market, for, Molecular Testing 2021 - 2033 (USD Million)